Cannabis Law Report

DECEMBER 3, 2021

.–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. Chief Executive Officer of Marinus Pharmaceuticals. “We Chief Executive Officer of Marinus Pharmaceuticals. “We Ganaxolone was generally well-tolerated and no new safety findings emerged in the LGS subgroup. change in MMSF).

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

MMJ Recs

NOVEMBER 17, 2023

The community impact is visible in several key areas: Healthcare Advancements MMJ has expanded the range of treatment options available to patients, offering an alternative to conventional pharmaceuticals. MMJ is known for its efficacy in treating various medical issues, including chronic pain, epilepsy, multiple sclerosis, and more.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

NORML

AUGUST 26, 2019

There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. These were moms and dads and grandparents of children [with intractable epilepsy] who were using medical cannabis oils. As in, no to anyone who wasn’t an epilepsy patient.].

Marijuana 213

Marijuana Legalization Programs Oil 213

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Refractory paediatric epilepsy. At the same time, the outlook on cannabis research data is largely positive. Conclusions.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 26, 2019

Fried also strongly delivered a message that could have been taken straight out of my own mouth: “This is a plant that not only improves people’s quality of life, it’s an alternative to sometimes-dangerous pharmaceuticals and addictive opioids.” Jacel Delgadillo. Eric Stevens. Antoinette Duncan. 15, Peter Barsoom.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Essay: “Combining Social Sciences and Pharmacology to Make a Positive Social Impact in Cannabis” . School: University of Maryland.

Research and Development 117

Research and Development Education Agriculture Patients 117

The Cannigma

DECEMBER 22, 2021

We have autism and epilepsy. It has the – you assume safety, at least to a certain level. That’s a shame that we don’t have a system that allows us to fast-track clinical trials, treating cannabis really as something that is different from proper pharmaceutical drugs and their whole three steps, etc.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79